Pacira BioSciences, Inc.

PCRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$276,774$153,298$104,139$585,578
Short-Term Investments$207,841$125,283$184,512$70,831
Receivables$113,304$105,556$98,397$96,318
Inventory$125,282$104,353$96,063$98,550
Other Curr. Assets$21,929$21,504$15,223$14,771
Total Curr. Assets$745,130$509,994$498,334$866,048
Property Plant & Equip (Net)$216,391$234,947$254,389$264,811
Goodwill$0$163,243$163,243$145,175
Intangibles$425,970$483,258$540,546$623,968
Long-Term Investments$29,449$2,410$37,209$0
Tax Assets$130,376$144,485$160,309$153,364
Other NC Assets$6,200$36,049$27,170$21,987
Total NC Assets$808,386$1,064,392$1,182,866$1,209,305
Other Assets$0$0$0$0
Total Assets$1,553,516$1,574,386$1,681,200$2,075,353
Liabilities
Payables$19,133$15,698$15,220$10,543
Short-Term Debt$210,663$17,442$42,769$382,591
Tax Payable$0$0$0$429
Deferred Revenue$0$0$0$0
Other Curr. Liab.$80,124$64,243$89,785$127,555
Total Curr. Liab.$309,920$97,383$147,774$521,118
LT Debt$428,190$568,602$720,625$746,257
Deferred Rev, NC$0$0$0$10,125
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$37,058$38,271$37,791$67,445
Total NC Liab.$465,248$606,873$758,416$823,827
Other Liabilities$0$0$0$0
Cap. Leases$53,532$63,607$73,923$79,618
Total Liabilities$775,168$704,256$906,190$1,344,945
Equity
Pref Stock$0$0$0$0
Common Stock$47$46$46$45
Retained Earnings-$206,356-$106,796-$148,751-$211,895
AOCI$343$247-$380$167
Other Equity$984,314$976,633$924,095$942,091
Total Equity$778,348$870,130$775,010$730,408
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,553,516$1,574,386$1,681,200$2,075,353
Net Debt$362,079$432,746$659,255$543,270
Pacira BioSciences, Inc. (PCRX) Financial Statements & Key Stats | AlphaPilot